Rosaramicin
![]() | |
| Names | |
|---|---|
| IUPAC name
(1S,2R,3R,7R,8S,9S,10R,12R,14E,16S)-3-Ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl 3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranoside | |
| Other names
Rosamicin; Juvenimicin A3 | |
| Identifiers | |
| ChEBI | CHEBI:87084 |
| ChEMBL | ChEMBL8965 |
| ChemSpider | 5020508 |
| Jmol interactive 3D | Image |
| PubChem | 6537204 |
| |
| |
| Properties | |
| C31H51NO9 | |
| Molar mass | 581.75 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Rosaramicin (rosamicin) is an antibacterial substance chemically a lipid-soluble basic macrolide similar to erythromycin but with a better activity against Gram-negative bacteria.
Experiments in dogs have shown that it is more concentrated in the prostate than erythromycin is, and thus may be better for treating infections of that organ. [1]
References
This article is issued from Wikipedia - version of the Tuesday, August 04, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
